Cell and gene therapies are notoriously difficult to characterize. Yet, early and thorough characterization is key to advancing therapeutic programs quickly with minimal risk of safety issues or clinical holds. Whether a therapy utilizes gene transfer technologies or gene editing tools, both approaches result in heterogeneity. Some cells have the desired changes while others do not, and some may even have alterations that pose a safety risk. Learn more about how Mission Bio can help you characterize your cell and gene therapies better.
